NYSE · TAC
TransAlta financials
$11.79−0.17%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.75B | $1.98B | $2.53B | $2.19B | $2.15B | $1.65B | $1.80B | $1.66B | $1.78B | $1.79B |
| Gross profit | $1.03B | $1.25B | $1.65B | $1.20B | $1.18B | $890.0M | $969.7M | $847.0M | $995.2M | $1.07B |
| Gross margin | 59.0% | 63.1% | 65.1% | 54.9% | 54.7% | 53.9% | 53.7% | 51.1% | 56.0% | 59.8% |
| Operating income | $102.0M | $407.6M | $821.9M | $391.3M | -$189.1M | -$77.8M | $257.6M | $118.0M | $106.4M | $212.2M |
| Net income | -$138.4M | $123.3M | $486.0M | $2.9M | -$455.7M | -$263.9M | $40.0M | -$182.8M | -$123.3M | $87.1M |
| Net margin | −7.9% | 6.2% | 19.2% | 0.1% | −21.2% | −16.0% | 2.2% | −11.0% | −6.9% | 4.9% |
| Diluted EPS | $-0.47 | $0.41 | $1.76 | $0.01 | $-1.69 | $-0.96 | $0.14 | $-0.63 | $-0.43 | $0.31 |
| EBITDA | $514.4M | $809.7M | $1.25B | $839.4M | $892.5M | $615.1M | $711.3M | $579.4M | $667.6M | $727.6M |
| Operating cash flow | $470.7M | $554.7M | $1.10B | $646.3M | $792.0M | $551.5M | $652.9M | $604.5M | $482.6M | $554.1M |
| Free cash flow | $289.2M | $338.0M | $444.5M | -$30.2M | $412.2M | $169.7M | $332.2M | $400.3M | $222.0M | $287.5M |
| Diluted shares | 297.0M | 302.0M | 276.0M | 271.0M | 271.0M | 275.0M | 283.0M | 287.0M | 288.0M | 288.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $149.4M | $234.8M | $262.6M | $835.7M | $749.3M | $552.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $3.16B | $3.18B | $2.62B | $2.70B | $2.58B | $2.64B |
| Total assets | $6.31B | $6.62B | $6.54B | $7.92B | $7.30B | $7.66B |
| Total liabilities | $5.24B | $5.33B | $5.28B | $6.45B | $5.25B | $4.96B |
| Shareholders' equity | $1.07B | $1.28B | $1.26B | $1.47B | $2.05B | $2.70B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology